Author

S. Bliss

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Research Focus:cell type annotation· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

R. M. Spaapen· 4 shared A. A. de Waard· 3 shared M. L. M. Jongsma· 3 shared T. Verkerk· 3 shared A. H. de Ru· 2 shared A. Mulder· 2 shared F. H. J. Claas· 2 shared K. Hoefakker· 2 shared

Activity by Year

2020-2020 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

R. M. Spaapen

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Soluble FAS Ligand directs human memory B cells towards antibody-secreting cells

S. D. van Asten, P.-P. Unger, C. Marsman, S. Bliss, T. Jorritsma, N. M. Thielens, S. M. van Ham, R. M. Spaapen

This study identifies soluble FAS ligand as a factor promoting memory B cell differentiation into antibody-secreting cells, linking it to autoimmunity and potential therapeutic targets.

bioRxiv · Dec 4, 2020Immunology

The SPPL3-defined glycosphingolipid repertoire regulates immune responses by improving HLA class I access

M. L. M. Jongsma, M. Raaben, A. A. de Waard, T. Zhang, B. Cabukusta, R. Platzer, V. A. Blomen, A. Xagara, T. Verkerk, S. Bliss, L. Janssen, E. Stickel, S. Holst, R. Plomp, A. Mulder, , R. M. Spaapen

The paper identifies a glycosphingolipid (GSL) signature that inhibits HLA-I antigen presentation and shows its reversal by clinically approved drugs.

bioRxiv · Sep 26, 2020Immunology

Healthy cells functionally present TAP-independent SSR1 peptides: implications for selection of clinically relevant antigens

A. A. de Waard, T. Verkerk, K. Hoefakker, D. M. van der Steen, M. L. M. Jongsma, S. Bliss, A. H. de Ru, P. A. van Veelen, M. Griffioen, M. H. M. Heemskerk, R. M. Spaapen

The paper identifies TAP-independent antigen presentation in healthy cells using a T cell clone and highlights the need for comprehensive testing of healthy cell types to safely target antigens for immunotherapy.

bioRxiv · Jun 11, 2020Immunology

PAKC: A novel Panel of HLA class I Antigen presentation machinery Knockout Cells from the same genetic origin

A. A. de Waard, T. Verkerk, M. L. M. Jongsma, K. Hoefakker, S. Sethumadhavan, C. Gerke, S. Bliss, G. M. C. Janssen, A. H. de Ru, F. H. J. Claas, A. Mulder, R. Tampe, P. A. van Veelen, A. Halenius, R. M. Spaapen

The paper generates a panel of APM knockout cell lines to study HLA class I antigen presentation and its role in immune responses.

bioRxiv · Jan 24, 2020Immunology